We are live on ! Find out more
Wells Fargo

Wells Fargo Portfolio holdings

AUM $530B
1-Year Est. Return 22.01%
 

Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.

This Fund
S&P 500
This Quarter Est. Return
+5.76%
1 Year Est. Return
+22.01%
3 Year Est. Return
+63.17%
5 Year Est. Return
+74.8%
10 Year Est. Return
+285.95%
AUM
$308B
AUM Growth
+$24.5B
Cap. Flow
+$7.79B
Cap. Flow %
2.53%
Top 10 Hldgs %
14.22%
Holding
6,821
New
340
Increased
2,859
Reduced
2,496
Closed
297

Sector Composition

Rank Sector Weight
1 Technology 10.29%
2 Healthcare 9.07%
3 Financials 8.9%
4 Industrials 8.58%
5 Consumer Discretionary 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLPY
5476
DELISTED
Morgan Stanley Cushing MLP High Income Index ETN
MLPY
$25K ﹤0.01%
3,215
+215
+7% +$1.74K
JMEI
5477
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$25K ﹤0.01%
+664
New +$27.6K
BBU
5478
DELISTED
Brookfield Business Partners
BBU
$24K ﹤0.01%
1,497
-242
-14% -$3.88K
BMY icon
5479
CALL
Bristol-Myers Squibb
BMY
$132B
$24K ﹤0.01%
3,400
-46,600
-93% -$2.56M
CVEO icon
5480
PUT
Civeo
CVEO
$350M
$24K ﹤0.01%
+6,250
New +$223K
GLMD icon
5481
Galmed Pharmaceuticals
GLMD
$4.95M
$24K ﹤0.01%
28
ICAD
5482
DELISTED
iCAD Inc
ICAD
$24K ﹤0.01%
5,076
-7,784
-61% -$30.2K
UG icon
5483
United-Guardian
UG
$33.2M
$24K ﹤0.01%
1,601
+1
+0.1% +$15
HSTO
5484
DELISTED
Histogen Inc. Common Stock
HSTO
$24K ﹤0.01%
21
-3
-13% -$2.9K
NAVB
5485
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$24K ﹤0.01%
2,050
-470
-19% -$5.34K
STI.WS.B
5486
DELISTED
Suntrust Banks Inc
STI.WS.B
$24K ﹤0.01%
1,800
VALE.P
5487
DELISTED
Vale S A
VALE.P
$24K ﹤0.01%
2,643
MOC
5488
DELISTED
Command Security Corporation
MOC
$24K ﹤0.01%
9,500
-500
-5% -$1.36K
FFBCW
5489
DELISTED
First Financial Bancorp. Warrant
FFBCW
$24K ﹤0.01%
1,500
FEEU
5490
DELISTED
Barclays ETN+ FI Enhanced Europe 50 ETN
FEEU
$24K ﹤0.01%
233
-419
-64% -$39.9K
DXJR
5491
DELISTED
WisdomTree Japan Hedged Real Estate Fund
DXJR
$24K ﹤0.01%
1,802
-585
-25% -$7.99K
AEF
5492
abrdn Emerging Markets Equity Income Fund
AEF
$348M
$23K ﹤0.01%
3,250
BAC icon
5493
PUT
Bank of America
BAC
$433B
$23K ﹤0.01%
124,500
-185,200
-60% -$4.4M
DHR icon
5494
PUT
Danaher
DHR
$138B
$23K ﹤0.01%
13,198
-9,700
-42% -$722K
PKBK icon
5495
Parke Bancorp
PKBK
$396M
$23K ﹤0.01%
1,464
SNDX icon
5496
Syndax Pharmaceuticals
SNDX
$1.73B
$23K ﹤0.01%
1,648
TACT icon
5497
Transact Technologies
TACT
$50.1M
$23K ﹤0.01%
2,885
TOVX icon
5498
Theriva Biologics
TOVX
$9.64M
$23K ﹤0.01%
4
WY icon
5499
CALL
Weyerhaeuser
WY
$16.9B
$23K ﹤0.01%
77,500
-60,000
-44% -$1.95M
TCF.WS
5500
DELISTED
TCF Financial Corporation
TCF.WS
$23K ﹤0.01%
10,000

Similar funds

Wells Fargo's Q1 2017 Portfolio in Review

As of Q1 2017, Wells Fargo held 6,821 positions worth $308B, up 8.6% from $283B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Wells Fargo's Q1 2017 filing shows 340 new, 2,859 increased, 2,496 reduced and 297 closed positions. Its largest new stake was Bioverativ Inc. Common Stock: 1,728,127 shares worth $94.1M. The largest sale was iShares Russell 2000 ETF, an estimated $341M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.

  • Wells Fargo's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 1,728,127 shares worth $94.1M.
  • Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $3.87B increase.
  • Wells Fargo's biggest Q1 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $341M.
  • Wells Fargo fully exited Harman International Industries in Q1 2017, selling an estimated $130M.
  • Wells Fargo's ten largest holdings make up 14% of its $308B portfolio in Q1 2017.
  • Wells Fargo opened 340 new positions and closed 297 in Q1 2017.
  • Wells Fargo's portfolio value rose 8.6% quarter-over-quarter to $308B.

Based on Wells Fargo's 13F filing for Q1 2017, filed 28 Apr 2017.